The Global Car T-cell Therapy Market is forescasted to grow at a CAGR of 63.15% during the period 2018-2022

Wednesday, October 10, 2018 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Oct. 9, 2018 /PRNewswire/ -- About CAR T-cell TherapyChimeric antigen receptor (CAR) is one of the recent

innovations in the pharmaceutical industry for the treatment of serious, life-threatening diseases, typically in the areas of oncology. CARs are engineered receptors to attack cancer cells. In this therapy, patients' T-cells are modified to attack cancer
cells. In this therapy, patients' T-cells are modified in the laboratory to fight against various cancer indications.Download the full report: https://www.reportbuyer.com/product/5583968 Technavio's analysts forecast the Global CAR T-cell Therapy Market to grow at a CAGR of 63.15% during the period 2018-2022.Covered in this reportThe report covers the present scenario and the growth prospects of the CAR T-cell therapy market. To calculate the market size, the report considers the revenue generated from the application of CAR T-cell therapy across the globe.The market is divided into the following segments based on geography:• Americas• APAC• EMEATechnavio's report, CAR T-cell therapy market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.Key vendors• bluebird bio• CARsgen Therapeutics• Celgene• Gilead• NovartisMarket driver• Proven effectiveness of CAR T-cell therapy• For a full, detailed list, view our reportMarket challenge• High cost of CAR T-cell therapy• For a full, detailed list, view our reportMarket trend• Collaborative R&D efforts• For a full, detailed list, view our reportKey questions answered in this report• What will the market size be in 2022 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key vendors?• What are the strengths and weaknesses of the key vendors?You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.Download the full report: https://www.reportbuyer.com/product/5583968 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-global-car-t-cell-therapy-market-is-forescasted-to-grow-at-a-cagr-of-63-15-during-the-period-2018-2022--300727771.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store